Clinical trial site matching with improved diversity using fair policy learning

• URL: http://arxiv.org/abs/2204.06501v1
• Date: Wed, 13 Apr 2022 16:35:28 GMT
• Title: Clinical trial site matching with improved diversity using fair policy learning
• Authors: Rakshith S Srinivasa, Cheng Qian, Brandon Theodorou, Jeffrey Spaeder, Cao Xiao, Lucas Glass, Jimeng Sun
• Abstract summary: We learn a model that maps a clinical trial description to a ranked list of potential trial sites. Unlike existing fairness frameworks, the group membership of each trial site is non-binary. We propose fairness criteria based on demographic parity to address such a multi-group membership scenario.
• Score: 56.01170456417214
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: The ongoing pandemic has highlighted the importance of reliable and efficient clinical trials in healthcare. Trial sites, where the trials are conducted, are chosen mainly based on feasibility in terms of medical expertise and access to a large group of patients. More recently, the issue of diversity and inclusion in clinical trials is gaining importance. Different patient groups may experience the effects of a medical drug/ treatment differently and hence need to be included in the clinical trials. These groups could be based on ethnicity, co-morbidities, age, or economic factors. Thus, designing a method for trial site selection that accounts for both feasibility and diversity is a crucial and urgent goal. In this paper, we formulate this problem as a ranking problem with fairness constraints. Using principles of fairness in machine learning, we learn a model that maps a clinical trial description to a ranked list of potential trial sites. Unlike existing fairness frameworks, the group membership of each trial site is non-binary: each trial site may have access to patients from multiple groups. We propose fairness criteria based on demographic parity to address such a multi-group membership scenario. We test our method on 480 real-world clinical trials and show that our model results in a list of potential trial sites that provides access to a diverse set of patients while also ensuing a high number of enrolled patients.

Related papers

• TrialBench: Multi-Modal Artificial Intelligence-Ready Clinical Trial Datasets [57.067409211231244]
  This paper presents meticulously curated AIready datasets covering multi-modal data (e.g., drug molecule, disease code, text, categorical/numerical features) and 8 crucial prediction challenges in clinical trial design. We provide basic validation methods for each task to ensure the datasets' usability and reliability. We anticipate that the availability of such open-access datasets will catalyze the development of advanced AI approaches for clinical trial design.
  arXiv  Detail & Related papers  (2024-06-30T09:13:10Z)
• Panacea: A foundation model for clinical trial search, summarization, design, and recruitment [29.099676641424384]
  We propose a clinical trial foundation model named Panacea. Panacea is designed to handle multiple tasks, including trial search, trial summarization, trial design, and patient-trial matching. We also assemble a large-scale dataset, named TrialAlign, of 793,279 trial documents and 1,113,207 trial-related scientific papers.
  arXiv  Detail & Related papers  (2024-06-25T21:29:25Z)
• AutoTrial: Prompting Language Models for Clinical Trial Design [53.630479619856516]
  We present a method named AutoTrial to aid the design of clinical eligibility criteria using language models. Experiments on over 70K clinical trials verify that AutoTrial generates high-quality criteria texts.
  arXiv  Detail & Related papers  (2023-05-19T01:04:16Z)
• Improving Patient Pre-screening for Clinical Trials: Assisting Physicians with Large Language Models [0.0]
  Large Language Models (LLMs) have shown to perform well for clinical information extraction and clinical reasoning. This paper investigates the use of InstructGPT to assist physicians in determining eligibility for clinical trials based on a patient's summarised medical profile.
  arXiv  Detail & Related papers  (2023-04-14T21:19:46Z)
• Towards Fair Patient-Trial Matching via Patient-Criterion Level Fairness Constraint [50.35075018041199]
  This work proposes a fair patient-trial matching framework by generating a patient-criterion level fairness constraint. The experimental results on real-world patient-trial and patient-criterion matching tasks demonstrate that the proposed framework can successfully alleviate the predictions that tend to be biased.
  arXiv  Detail & Related papers  (2023-03-24T03:59:19Z)
• Adaptive Identification of Populations with Treatment Benefit in Clinical Trials: Machine Learning Challenges and Solutions [78.31410227443102]
  We study the problem of adaptively identifying patient subpopulations that benefit from a given treatment during a confirmatory clinical trial. We propose AdaGGI and AdaGCPI, two meta-algorithms for subpopulation construction.
  arXiv  Detail & Related papers  (2022-08-11T14:27:49Z)
• Patient Aware Active Learning for Fine-Grained OCT Classification [12.89552245538411]
  We propose a framework that incorporates clinical insights into the sample selection process of active learning. Our medically interpretable active learning framework captures diverse disease manifestations from patients to improve performance of OCT classification.
  arXiv  Detail & Related papers  (2022-06-23T05:47:51Z)
• Multi-disciplinary fairness considerations in machine learning for clinical trials [43.00377806138086]
  We focus on clinical trials, i.e., research studies conducted on humans to evaluate medical treatments. Our aim is to provide a multi-disciplinary assessment of how fairness for machine learning fits into the context of clinical trials research and practice.
  arXiv  Detail & Related papers  (2022-05-18T11:59:22Z)
• Contextual Constrained Learning for Dose-Finding Clinical Trials [102.8283665750281]
  C3T-Budget is a contextual constrained clinical trial algorithm for dose-finding under both budget and safety constraints. It recruits patients with consideration of the remaining budget, the remaining time, and the characteristics of each group.
  arXiv  Detail & Related papers  (2020-01-08T11:46:48Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.